TP-808

CAS No. 852821-06-8

TP-808( TP808 | TP-808 | TP 808 )

Catalog No. M17619 CAS No. 852821-06-8

Detail unknown.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 201 In Stock
10MG 295 In Stock
25MG 500 In Stock
50MG 705 In Stock
100MG 981 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TP-808
  • Note
    Research use only, not for human use.
  • Brief Description
    Detail unknown.
  • Description
    TP808 is a useful intermediate for the synthesis of diverse tetracycline antibiotics.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    TP808 | TP-808 | TP 808
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    NADPH
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    852821-06-8
  • Formula Weight
    482.64
  • Molecular Formula
    C26H34N2O5Si
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)(C)[Si](C)(C)O[C@@]12[C@@H](CC=CC1=O)[C@@H](c1c(C2=O)c(no1)OCc1ccccc1)N(C)C
  • Chemical Name
    (4aS,8aS,9S)-3-(Benzyloxy)-4a-((tert-butyldimethylsilyl)oxy)-9-(dimethylamino)-8a,9-dihydronaphtho[2,3-d]isoxazole-4,5(4aH,8H)-dione

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • gp91 ds-tat

    gp91 ds-tat is a NADPH oxidase (NOX2) inhibitor that reduces NOX2 expression.

  • 5-Heneicosylresorcin...

    5-Heneicosylresorcinol shows inhibitory effects on the release of β-hexosaminidase from RBL-2H3 cells, it also prevents triglyceride accumulation in 3T3-L1 cells. 5-Heneicosylresorcinol has nematicidal activity against nematodes Panagrellus redivivus, Caenothabditis elegans and Bursaphelenchus xylophilus, with ED50 values of 80, 30, and 180 ug/mL, respectively.

  • NQO1 substrate

    NQO1 substrate is a highly potent NQO1 substrate with potential antitumor activity for leukemia research.